Contract 75F40125C00069
Genentech Inc · Department Of Health And Human Services · September 11, 2025
Genentech Inc was awarded a federal contract by Department Of Health And Human Services (Food And Drug Administration) on September 11, 2025 for $1.09 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Silver Spring, MD. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on March 20, 2026.
Contract details
- PIID
- 75F40125C00069
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- General Science And Technology R&D Services; General Science And Technology; Basic Research
- Place of performance
- Silver Spring, MD
- First action
- September 11, 2025
- Latest action
- March 20, 2026
Description
THIS PROJECT FOCUSES ON ADDRESSING CRITICAL CHALLENGES IN THE DESIGN AND ANALYSIS OF HYBRID RANDOMIZED CONTROLLED TRIALS (RCTS) IN LONGITUDINAL SETTINGS. THE FIRST GOAL IS TO DEVELOP CAUSAL METHODOLOGIES FOR MANAGING DIVERSE MISSING DATA PATTERNS IN
Modification timeline
-
March 20, 2026Mod P00001 · Other Administrative Action$1.09M
-
September 11, 2025Base award$1.09M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75F40125C00069?
Contract 75F40125C00069 is a federal contract awarded to Genentech Inc by Department Of Health And Human Services on September 11, 2025 for $1.09 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75F40125C00069?
Genentech Inc won contract 75F40125C00069 from Department Of Health And Human Services.
How much is contract 75F40125C00069 worth?
Contract 75F40125C00069 has obligated $1.09 million to date.